Tandem Diabetes Care Inc
TNDM
Market Cap$2B
Close$
$-0.43
101.2% downside
Current Fair Value
101.2% downsideOvervalued by 101.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.00 Billion |
|---|---|
| Enterprise Value | $1.81 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.43 |
| Beta | 1.21 |
| Outstanding Shares | 64,563,476 |
| Avg 30 Day Volume | 1,353,754 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.97 |
|---|---|
| PEG | -10.05 |
| Price to Sales | 3.18 |
| Price to Book Ratio | 8.74 |
| Enterprise Value to Revenue | 2.43 |
| Enterprise Value to EBIT | -11.74 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.91 |
Revenue Sources
No data
ESG Score
No data
About Tandem Diabetes Care Inc
1,600 employees
CEO: John Sheridan Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach t...